COVID-19 Candidates
The goal of GEN's resource is to provide an up-to-date comprehensive collection of news, milestones and updates on more than 300 drug and vaccine candidates currently being developed for the COVID-19 pandemic. To help navigate through the potential therapeutic options for COVID-19, GEN had divided this list of candidates into four broad categories based on their developmental and (where applicable) clinical progress. The numbers of verified candidates ballooned rapidly from 35 in February 2020, to 60 in March, to 160 in April, and well over 300 as of June 2021. From the start of this list several vaccines have received an EUA.